病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识

2025-07-16 中国胸心血管外科临床杂志 发表于上海

旨在为临床提供科学、可操作的评估工具,提升患者甄选的准确性与移植成功率。

中文标题:

病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识

发布机构:

发布日期:

2025-07-16

简要介绍:

由高致病性病毒引发的重症病毒性肺炎,常导致急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS),并进展为不可逆肺纤维化和慢性呼吸衰竭。随着肺移植技术发展,肺移植已成为终末期病毒性肺损伤患者的重要治疗方式。但因其病程复杂,临床上缺乏标准化评估与时机判断依据。因此,我们组织由多学科专家,基于国内外循证医学资料与临床实践,总结病毒性肺损伤患者肺移植评估的核心原则与推荐条目,共同制定此共识。内容涵盖肺移植适应证、影像与功能评估、病毒控制标准、生存获益与术后康复潜力等关键维度,强调在肺结构不可逆、病毒控制稳定、患者全身状况尚可的“窗口期”内及时干预。共识采用定量系统评价证据分级工具(Grading of Recommendations Assessment,Development and Evaluation,GRADE)系统对证据等级与推荐强度进行分级,旨在为临床提供科学、可操作的评估工具,提升患者甄选的准确性与移植成功率。

相关资料下载:
[AttachmentFileName(sort=1, fileName=病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0c9e81c00a43297f, title=病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识, enTitle=, guiderFrom=中国胸心血管外科临床杂志, authorId=0, author=, summary=旨在为临床提供科学、可操作的评估工具,提升患者甄选的准确性与移植成功率。, cover=https://img.medsci.cn/20250122/1737522567541_8538692.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Jul 16 00:00:00 CST 2025, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">由高致病性病毒引发的重症病毒性肺炎,常导致急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS),并进展为不可逆肺纤维化和慢性呼吸衰竭。随着肺移植技术发展,肺移植已成为终末期病毒性肺损伤患者的重要治疗方式。但因其病程复杂,临床上缺乏标准化评估与时机判断依据。因此,我们组织由多学科专家,基于国内外循证医学资料与临床实践,总结病毒性肺损伤患者肺移植评估的核心原则与推荐条目,共同制定此共识。内容涵盖肺移植适应证、影像与功能评估、病毒控制标准、生存获益与术后康复潜力等关键维度,强调在肺结构不可逆、病毒控制稳定、患者全身状况尚可的&ldquo;窗口期&rdquo;内及时干预。共识采用定量系统评价证据分级工具(Grading of Recommendations Assessment,Development and Evaluation,GRADE)系统对证据等级与推荐强度进行分级,旨在为临床提供科学、可操作的评估工具,提升患者甄选的准确性与移植成功率。</span></div>, tagList=[TagDto(tagId=506556, tagName=病毒性肺损伤)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=506556, articleKeyword=病毒性肺损伤, articleKeywordNum=6, guiderKeywordId=506556, guiderKeyword=病毒性肺损伤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=674, appHits=25, showAppHits=0, pcHits=8, showPcHits=649, likes=0, shares=12, comments=6, approvalStatus=1, publishedTime=Fri Jul 18 22:12:00 CST 2025, publishedTimeString=2025-07-16, pcVisible=1, appVisible=1, editorId=0, editor=pangpanglong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=pangpanglong, createdTime=Wed Jul 16 13:23:14 CST 2025, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Fri Jul 18 18:49:53 CST 2025, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识.pdf)])
病毒性肺损伤所致呼吸衰竭患者肺移植评估专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2273951, encodeId=666922e395149, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb026286625, createdName=135672_1610, createdTime=Sat Jul 19 06:08:10 CST 2025, time=7小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273942, encodeId=69fd22e394294, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sat Jul 19 00:20:30 CST 2025, time=13小时前, status=0, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2273937, encodeId=dc7d22e39373e, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=纪磊, createdTime=Fri Jul 18 23:25:10 CST 2025, time=14小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273934, encodeId=3c6c22e39344c, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4406448235, createdName=刘桂林, createdTime=Fri Jul 18 23:23:57 CST 2025, time=14小时前, status=0, ipAttribution=辽宁省)]
    7小时前 135672_1610 来自山东省
  2. [GetPortalCommentsPageByObjectIdResponse(id=2273951, encodeId=666922e395149, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb026286625, createdName=135672_1610, createdTime=Sat Jul 19 06:08:10 CST 2025, time=7小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273942, encodeId=69fd22e394294, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sat Jul 19 00:20:30 CST 2025, time=13小时前, status=0, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2273937, encodeId=dc7d22e39373e, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=纪磊, createdTime=Fri Jul 18 23:25:10 CST 2025, time=14小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273934, encodeId=3c6c22e39344c, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4406448235, createdName=刘桂林, createdTime=Fri Jul 18 23:23:57 CST 2025, time=14小时前, status=0, ipAttribution=辽宁省)]
    13小时前 Dew· 来自新疆
  3. [GetPortalCommentsPageByObjectIdResponse(id=2273951, encodeId=666922e395149, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb026286625, createdName=135672_1610, createdTime=Sat Jul 19 06:08:10 CST 2025, time=7小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273942, encodeId=69fd22e394294, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sat Jul 19 00:20:30 CST 2025, time=13小时前, status=0, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2273937, encodeId=dc7d22e39373e, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=纪磊, createdTime=Fri Jul 18 23:25:10 CST 2025, time=14小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273934, encodeId=3c6c22e39344c, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4406448235, createdName=刘桂林, createdTime=Fri Jul 18 23:23:57 CST 2025, time=14小时前, status=0, ipAttribution=辽宁省)]
    14小时前 纪磊 来自山东省
  4. [GetPortalCommentsPageByObjectIdResponse(id=2273951, encodeId=666922e395149, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb026286625, createdName=135672_1610, createdTime=Sat Jul 19 06:08:10 CST 2025, time=7小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273942, encodeId=69fd22e394294, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Sat Jul 19 00:20:30 CST 2025, time=13小时前, status=0, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2273937, encodeId=dc7d22e39373e, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=纪磊, createdTime=Fri Jul 18 23:25:10 CST 2025, time=14小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2273934, encodeId=3c6c22e39344c, content=前往app查看评论内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4406448235, createdName=刘桂林, createdTime=Fri Jul 18 23:23:57 CST 2025, time=14小时前, status=0, ipAttribution=辽宁省)]
    14小时前 刘桂林 来自辽宁省